share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股SEC公告 ·  08/29 16:56

Moomoo AI 已提取核心信息

Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares of the company, with an aggregate market value of $45,376.21, on 08/29/2024. The shares were originally acquired on the same date through an option granted on 07/23/2018. Over the past three months, a total of 15,000 shares have been sold by the officer, generating gross proceeds of $118,334.40. The upcoming sale is part of a planned transaction set on 03/01/2024.
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares of the company, with an aggregate market value of $45,376.21, on 08/29/2024. The shares were originally acquired on the same date through an option granted on 07/23/2018. Over the past three months, a total of 15,000 shares have been sold by the officer, generating gross proceeds of $118,334.40. The upcoming sale is part of a planned transaction set on 03/01/2024.
Recursion Pharmaceuticals, Inc.的高管Marriott Tina计划在2024年08月29日卖出公司的6000股A类股票,市值为45376.21美元。这些股票最初是在2018年07月23日通过授予的期权获得的。在过去的三个月里,该高管已经卖出了总共15000股股票,总收益为118334.40美元。即将到来的销售是计划于2024年03月01日进行的交易的一部分。
Recursion Pharmaceuticals, Inc.的高管Marriott Tina计划在2024年08月29日卖出公司的6000股A类股票,市值为45376.21美元。这些股票最初是在2018年07月23日通过授予的期权获得的。在过去的三个月里,该高管已经卖出了总共15000股股票,总收益为118334.40美元。即将到来的销售是计划于2024年03月01日进行的交易的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息